Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Journal of Cardiac Surgery|May 12, 2022
Effect of nadir hematocrit during cardiopulmonary bypass on the early outcomes after surgical repair of acute type A aortic dissectionYoshihiko Chiba, Yasushi Tashima, Shinnosuke Ohama, et al.
Plos One|August 10, 2012
Forced expression of miR-143 represses ERK5/c-Myc and p68/p72 signaling in concert with miR-145 in gut tumors of Apc(Min) miceYuji Takaoka, Yuko Shimizu, Hitoki Hasegawa, et al.
Neuroscience Letters|April 2, 2014
Mitogen-activated protein kinase phosphatase 1 negatively regulates MAPK signaling in mouse hypothalamusKoichi Adachi, Motomitsu Goto, Takeshi Onoue, et al.
The Journal of Dermatology|December 6, 2016
Burden of herpes zoster and postherpetic neuralgia in Japanese adults 60 years of age or older: Results from an observational, prospective, physician practice-based cohort studyKeiko Sato, Koichi Adachi, Hiroyuki Nakamura, et al.
The American Journal of Cardiology|February 4, 2014
Utility of the Penn classification in predicting outcomes of surgery for acute type a aortic dissectionNaoyuki Kimura, Tetsu Ohnuma, Satoshi Itoh, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 25, 2013
GABA type B receptor signaling in proopiomelanocortin neurons protects against obesity, insulin resistance, and hypothalamic inflammation in male mice on a high-fat dietYoshihiro Ito, Ryoichi Banno, Miyuki Shibata, et al.
Cellular & Molecular Biology Letters|August 29, 2020
Forced expression of miR-143 and -145 in cardiomyocytes induces cardiomyopathy with a reductive redox shiftKota Ogawa, Akiko Noda, Jun Ueda, et al.
Drugs - Real World Outcomes|October 9, 2017
Economic Burden of Herpes Zoster and Post-Herpetic Neuralgia in Adults 60 Years of Age or Older: Results from a Prospective, Physician Practice-Based Cohort Study in Kushiro, JapanHiroyuki Nakamura, Akiko Mizukami, Koichi Adachi, et al.
Bone|April 10, 2022
Randomized controlled trial of daily teriparatide, weekly high-dose teriparatide, or bisphosphonate in patients with postmenopausal osteoporosis: The TERABIT studyKo Chiba, Narihiro Okazaki, Ayako Kurogi, et al.
Pageof 5